职务:复旦大学放射医学研究所所长
电子邮箱:nzhang@fudan.edu.cn
办公地点:复旦大学枫林校区东一号楼205室
电话:18017366728
研究方向
学术任职
科研成果
分子病理学
肾脏病理
间质病理学
中华医学会医学科研管理研究学会常委
发表论文:
W. Zeng et al., The Angiogenic Makeup of Human Hepatocellular Carcinoma Does Not Favor Vascular Endothelial Growth Factor/Angiopoletin-Driven Sprouting Neovascularization. Hepatology 48, 1517-1527 (2008)
Z.-S. Wu et al., miR-340 Inhibition of Breast Cancer Cell Migration and Invasion Through Targeting of Oncoprotein c-Met. Cancer 117, 2842-2852 (2011).
G. Shang et al., HGF-mediated inhibition of oxidative stress by 8-nitro-cGMP in high glucose-treated rat mesangial cells. Free Radical Research 46, 1238-1248 (2012).
T. Jiang et al., Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappa B-mediated inflammatory response. Kidney International 85, 333-343 (2014).
P. Gao et al., Synergistic effects of c-Jun and SP1 in the promotion of TGF beta 1-mediated diabetic nephropathy progression. Experimental and Molecular Pathology 100, 441-450 (2016).
D. Liu et al., Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression. Oncotarget 7, 65389-65402 (2016).
Y. Wei et al., PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62. Cancer Medicine 5, 3520-3531 (2016).
P. Gao et al., Diagnostic errors in fatal medical malpractice cases in Shanghai, China: 1990-2015. Diagnostic Pathology 14, (2019).
B. Hou et al., HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3 beta-TFEB axis. Cellular Signalling 75, (2020).
X. Miao, N. Zhang, Role of RBM3 in the regulation of cell proliferation in hepatocellular carcinoma. Experimental and Molecular Pathology 117, (2020).